Meloxicam [Mobic] in Juvenile Rheumatoid Arthritis (JRA)

NCT00034853 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Arthritis, Juvenile Rheumatoid

Interventions

DRUG: meloxicam oral suspension
DRUG: naproxen oral suspension

Sponsor

Boehringer Ingelheim